Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

NCT01679470 is registered in ClinicalTrials.gov with Nanospectra Biosciences, Inc. as lead sponsor.

NCT NCT01679470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Lead sponsor
Nanospectra Biosciences, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2012
Completion date
June 30, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary or metastatic lung tumors